Neurones S.A. (EPA:NRO)
38.15
-0.30 (-0.78%)
Jul 31, 2026, 5:35 PM CET
Neurones Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 340.78 | 326.49 | 297.76 | 272.06 | 265.17 |
Cash & Short-Term Investments | 340.78 | 326.49 | 297.76 | 272.06 | 265.17 |
Cash Growth | 4.38% | 9.65% | 9.45% | 2.60% | -0.54% |
Accounts Receivable | 261.59 | 257.7 | 242.98 | 227.79 | 195.84 |
Inventory | 0.02 | 0.27 | 0.71 | 0.35 | 0.89 |
Other Current Assets | 6.14 | 3.65 | 4.37 | 6.37 | 2.23 |
Total Current Assets | 608.53 | 588.11 | 545.81 | 506.57 | 464.13 |
Net Property, Plant & Equipment | 59.37 | 60.53 | 58.73 | 48.77 | 46.1 |
Other Intangible Assets | 62.7 | 58.19 | 54.71 | 46.07 | 45.86 |
Long-Term Investments | 12.17 | 11.96 | 10.75 | 9.52 | 8.28 |
Other Long-Term Assets | 6.26 | 6.9 | 6.1 | 5.28 | 3.45 |
Total Assets | 749.03 | 725.69 | 676.1 | 616.22 | 567.82 |
Accounts Payable | 235.44 | 234.53 | 209.99 | 189.22 | 169.86 |
Accrued Expenses | 2.75 | 1.98 | 2.37 | 1.7 | 1.48 |
Short-Term Debt | 3.41 | 4.96 | 5.87 | 0.17 | 0.33 |
Current Portion of Leases | 7.59 | 7.61 | 7.22 | 8.01 | 7.29 |
Other Current Liabilities | 0.88 | 3.58 | 3.48 | 7.99 | 5.6 |
Total Current Liabilities | 250.06 | 252.66 | 228.92 | 207.1 | 184.56 |
Long-Term Debt | 0.76 | 2.05 | 1.51 | 0.11 | 0.2 |
Long-Term Leases | 25.26 | 27.44 | 29.42 | 27.3 | 27.62 |
Other Long-Term Liabilities | 8.09 | 7.37 | 6.5 | 6.13 | 2.52 |
Total Long-Term Liabilities | 34.11 | 36.86 | 37.42 | 33.53 | 30.34 |
Total Liabilities | 284.16 | 289.52 | 266.34 | 240.64 | 214.9 |
Common Stock | 9.73 | 9.71 | 9.71 | 9.69 | 9.69 |
Additional Paid-in Capital | 16.26 | 16.28 | 31.38 | 31.4 | 31.4 |
Retained Earnings | 373.99 | 352.12 | 314.66 | 289.49 | 270.47 |
Total Common Shareholders' Equity | 399.98 | 378.1 | 355.75 | 330.58 | 311.56 |
Minority Interest | 64.89 | 58.07 | 54 | 45 | 41.36 |
Shareholders' Equity | 464.87 | 436.17 | 409.76 | 375.58 | 352.92 |
Total Liabilities & Equity | 749.03 | 725.69 | 676.1 | 616.22 | 567.82 |
Total Debt | 37.01 | 42.06 | 44.02 | 35.59 | 35.45 |
Net Cash (Debt) | 303.77 | 284.43 | 253.74 | 236.47 | 229.73 |
Net Cash Growth | 6.80% | 12.09% | 7.31% | 2.93% | -0.73% |
Net Cash Per Share | 12.46 | 11.68 | 10.44 | 9.73 | 9.47 |
Book Value | 399.98 | 378.1 | 355.75 | 330.58 | 311.56 |
Book Value Per Share | 16.41 | 15.53 | 14.63 | 13.61 | 12.85 |
Tangible Book Value | 337.28 | 319.91 | 301.04 | 284.51 | 265.7 |
Tangible Book Value Per Share | 13.84 | 13.14 | 12.38 | 11.71 | 10.96 |